Clinical trials sponsored by Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Phase breakdown

Conditions studied

Recruiting trials led by Karuna Therapeutics, Inc., a Bristol Myers Squibb company

• A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
  NCT05511363 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female) · 129 locations
• A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
  NCT06126224 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female) · 154 locations
• A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
  NCT06585787 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female) · 293 locations
• A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively
  NCT07424404 · Phase: Phase 3 · Ages: 5 Years to 17 Years · Sex: All (male and female) · 91 locations
• Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
  NCT05980949 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female) · 429 locations

Common questions

How many trials is Karuna Therapeutics, Inc., a Bristol Myers Squibb company recruiting for?

Karuna Therapeutics, Inc., a Bristol Myers Squibb company is the lead sponsor of 5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.